JAX Mouse Strain Datasheet - 002913

STOCK Gria2^tm1Rod/J

Stock No:: 002913 |; GluR2 KO

Targeted Mutation

Cryo Recovery

Overview

Also Known As: GluR2 KO

These Gria2 knock-out mice exhibit an increase in Ca²⁺ permeability and enhanced long-term potentiation in neurons. They are suitable for use in applications related to the study of Ca²⁺ permeability and plasticity of neurons in the central nervous system.

Donating Investigator

Dr. John Roder, University of Toronto

Genetic overview

Genetic Background	Generation

Gria2^tm1Rod

Allele Type	Gene Symbol	Gene Name
Targeted (Null/Knockout)	Gria2	glutamate receptor, ionotropic, AMPA2 (alpha 2)

View Genetics

Research Applications

Cell Biology Research
Neurobiology Research

View All Research Applications

Base Price

Starting at:

$2,595.00 Domestic price Cryo Recovery

View Price List

Details

Detailed Description

Mice homozygous for the Gria2^tm1Rod targeted mutation (GluR2) were originally reported to be about one half the size of their normal littermates by two to three weeks leading to some preweaning mortality. Growth retardation and mortality can be diminished by reducing litter size and eliminating some competition for the mother's milk. Homozygotes do appear similar in size and weight by eight weeks of age. Neurons lacking Gria2 exhibit a 9-fold increase in Ca2+ permeability and enhanced long-term potentiation (LTP). Antagonists of AMPA and NMDA receptors block all the enhanced LTP seen in homozygous null mice. Unpublished data show changes in pain thresholds, sensitivity to anaesthetics, focal cerebral ischemia, apoptosis of neuronal subpopulations and learning impairments.

It has been the experience of The Jackson Laboratory that no homozygous animals can be recovered from heterozygous sibling matings.

Control Suggestions

Wild-type from the colony

Additional Information

Considerations for Choosing Controls

Selected References

Jia Z; Agopyan N; Miu P; Xiong Z; Henderson J; Gerlai R; Taverna FA; Velumian A; MacDonald J; Carlen P; Abramow-Newerly W; Roder J. 1996. Enhanced LTP in mice deficient in the AMPA receptor GluR2. Neuron 17(5):945-56. PubMed: 8938126 MGI: J:64275

View All References

Genetics

Gria2^tm1Rod

Allele Symbol: Gria2^tm1Rod

Allele Name	targeted mutation 1, John Roder
Allele Type	Targeted (Null/Knockout)
Allele Synonym(s)	GluA2; GluR2-
Gene Symbol and Name	Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2)
Gene Synonym(s)	GLUR2; GLURB; GluA2; GluR-B; GluR-K2; GluR2; Glur-2; Glur-2; Glur2; Glur2; HBGR2; gluR-B; glutamate receptor 2 (alpha 2)
Strain of Origin	(129X1/SvJ x 129S1/Sv)F1-Kitl<+>
Chromosome	3
Molecular Note	A neomycin resistance cassette replaced exon 11 of the gene, which encodes the pore loop and transmembrane region, TM1. Western blots of brain plasma membranes from homozygous mutant mice showed no detectable protein for the targeted gene.
Mutations Made By	Dr. John Roder, University of Toronto

Disease/Phenotype

Disease Terms

Research Areas By Genotype

This mouse can be used to support research in many areas including:

Genotype: Gria2^tm1Rod related

Cell Biology Research
- Channel and Transporter Defects
Neurobiology Research
- Channel and Transporter Defects
  - sodium/potassium
- Epilepsy
- Receptor Defects
  - glutamate receptor: ionotropic

Mammalian Phenotype Terms by Genotype

Genotype: Gria2^tm1Rod/Gria2^tm1Rod
involves: 129S1/Sv * 129X1/SvJ * CD-1

mortality/aging

postnatal lethality, incomplete penetrance
- by 2 - 3 weeks of age about 20% of homozygotes die

behavior/neurological phenotype

abnormal reflex
- impaired eye closure reflex to approaching objects

abnormal response to novel object
- object exploration is reduced

decreased exploration in new environment

decreased grooming behavior

impaired coordination
- impaired coordination on rotorod test; however no signs of seizure activity were detected by observation, EEG, or post-mortem pyramidal cell dropout in the hippocampus

nervous system phenotype

enhanced long term potentiation
- LTP in CA1 region of the hippocampus is enhanced 2-fold and non-saturating

growth/size/body region phenotype

decreased body size
- body size is reduced at 2 - 3 weeks of age; however by 6 - 7 weeks, surviving homozygotes were the same size as littermates

decreased body weight
- body weight is reduced at 2 - 3 weeks of age; however by 6 - 7 weeks, surviving homozygotes were the same weight as littermates

The following phenotype information is associated with a similar, but not exact match to this JAX^® Mice strain

Genotype: Gria2^tm1Rod/Gria2⁺
B6.129-Gria2^tm1Rod/J

nervous system phenotype

abnormal AMPA-mediated synaptic currents
- high degree of inhibition by the external polyamine 1-naphtyl acetyl spermine (NAS), a strong inward rectification and a high relative Ca2+ permeability
- higher elevations of the intracellular Ca2+ concentration upon AMPA receptor stimulation
- normal number of AMPA receptors in the cell membrane

increased susceptibility to neuronal excitotoxicity
- increased vulnerability to AMPA receptor-mediated excitotoxicity

homeostasis/metabolism phenotype

increased susceptibility to neuronal excitotoxicity
- increased vulnerability to AMPA receptor-mediated excitotoxicity

cellular phenotype

increased susceptibility to neuronal excitotoxicity
- increased vulnerability to AMPA receptor-mediated excitotoxicity

Genotype: Gria2^tm1Rod/Gria2^tm1Rod
B6.129-Gria2^tm1Rod/J

nervous system phenotype

abnormal AMPA-mediated synaptic currents
- high degree of inhibition by the external NAS, a strong inward rectification and a high relative Ca2+ permeability
- higher elevations of the intracellular Ca2+ concentration upon AMPA receptor stimulation
- normal number of AMPA receptors in the cell membrane

increased susceptibility to neuronal excitotoxicity
- abolished AMPA receptor-mediated cell death in cultured motor neurons by the external polyamine 1-naphtyl acetyl spermine (NAS)
- increased vulnerability to AMPA receptor-mediated excitotoxicity

behavior/neurological phenotype

abnormal limb posture
- abnormal posturing of both forelimbs and hind limbs during manipulations

abnormal response to novel object
- reduced object exploration

decreased grip strength
- slightly lower grip strength in fore limbs

hypoactivity
- reduced spontaneous activity during the night

impaired coordination
- unable to walk on a rotarod

homeostasis/metabolism phenotype

increased susceptibility to neuronal excitotoxicity
- abolished AMPA receptor-mediated cell death in cultured motor neurons by the external polyamine 1-naphtyl acetyl spermine (NAS)
- increased vulnerability to AMPA receptor-mediated excitotoxicity

cellular phenotype

increased susceptibility to neuronal excitotoxicity
- abolished AMPA receptor-mediated cell death in cultured motor neurons by the external polyamine 1-naphtyl acetyl spermine (NAS)
- increased vulnerability to AMPA receptor-mediated excitotoxicity

References

Jia Z; Agopyan N; Miu P; Xiong Z; Henderson J; Gerlai R; Taverna FA; Velumian A; MacDonald J; Carlen P; Abramow-Newerly W; Roder J. 1996. Enhanced LTP in mice deficient in the AMPA receptor GluR2. Neuron 17(5):945-56. PubMed: 8938126 MGI: J:64275

Additional References

Hollmann M; Heinemann S. 1994. Cloned glutamate receptors. Annu Rev Neurosci 17:31-108. PubMed: 8210177 MGI: J:17259
Mead AN; Stephens DN. 2003. Involvement of AMPA receptor GluR2 subunits in stimulus-reward learning: evidence from glutamate receptor gria2 knock-out mice. J Neurosci 23(29):9500-7. PubMed: 14573529 MGI: J:86306

Additional - Gria2^tm1Rod related

Adesnik H; Nicoll RA. 2007. Conservation of glutamate receptor 2-containing AMPA receptors during long-term potentiation. J Neurosci 27(17):4598-602. PubMed: 17460072 MGI: J:121085
Biou V; Bhattacharyya S; Malenka RC. 2008. Endocytosis and recycling of AMPA receptors lacking GluR2/3. Proc Natl Acad Sci U S A 105(3):1038-43. PubMed: 18195348 MGI: J:131171
Gerlai R; Henderson JT; Roder JC; Jia Z. 1998. Multiple behavioral anomalies in GluR2 mutant mice exhibiting enhanced LTP. Behav Brain Res 95(1):37-45. PubMed: 9754875 MGI: J:78386
Gladding CM; Collett VJ; Jia Z; Bashir ZI; Collingridge GL; Molnar E. 2009. Tyrosine dephosphorylation regulates AMPAR internalisation in mGluR-LTD. Mol Cell Neurosci 40(2):267-79. PubMed: 19063969 MGI: J:146934
Harlow DE; Saul KE; Komuro H; Macklin WB. 2015. Myelin Proteolipid Protein Complexes with alphav Integrin and AMPA Receptors In Vivo and Regulates AMPA-Dependent Oligodendrocyte Progenitor Cell Migration through the Modulation of Cell-Surface GluR2 Expression. J Neurosci 35(34):12018-32. PubMed: 26311781 MGI: J:226168
Herring BE; Shi Y; Suh YH; Zheng CY; Blankenship SM; Roche KW; Nicoll RA. 2013. Cornichon proteins determine the subunit composition of synaptic AMPA receptors. Neuron 77(6):1083-96. PubMed: 23522044 MGI: J:197912
Hu RQ; Cortez MA; Man HY; Roder J; Jia Z; Wang YT; Snead OC 3rd. 2001. Gamma-hydroxybutyric acid-induced absence seizures in GluR2 null mutant mice. Brain Res 897(1-2):27-35. PubMed: 11282355 MGI: J:68428
Iihara K; Joo DT; Henderson J; Sattler R; Taverna FA; Lourensen S; Orser BA; Roder JC; Tymianski M. 2001. The influence of glutamate receptor 2 expression on excitotoxicity in Glur2 null mutant mice. J Neurosci 21(7):2224-39. PubMed: 11264298 MGI: J:68447
Jackson AC; Nicoll RA. 2011. Stargazin (TARP {gamma}-2) Is Required for Compartment-Specific AMPA Receptor Trafficking and Synaptic Plasticity in Cerebellar Stellate Cells. J Neurosci 31(11):3939-52. PubMed: 21411637 MGI: J:170457
Joo DT; Gong D; Sonner JM; Jia Z; MacDonald JF; Eger EI 2nd; Orser BA. 2001. Blockade of AMPA receptors and volatile anesthetics: reduced anesthetic requirements in GluR2 null mutant mice for loss of the righting reflex and antinociception but not minimum alveolar concentration. Anesthesiology 94(3):478-88. PubMed: 11374610 MGI: J:106294
Joo DT; Xiong Z; MacDonald JF; Jia Z; Roder J; Sonner J; Orser BA. 1999. Blockade of glutamate receptors and barbiturate anesthesia: increased sensitivity to pentobarbital-induced anesthesia despite reduced inhibition of AMPA receptors in GluR2 null mutant mice [see comments] Anesthesiology 91(5):1329-41. PubMed: 10551584 MGI: J:59684
Lu W; Shi Y; Jackson AC; Bjorgan K; During MJ; Sprengel R; Seeburg PH; Nicoll RA. 2009. Subunit composition of synaptic AMPA receptors revealed by a single-cell genetic approach. Neuron 62(2):254-68. PubMed: 19409270 MGI: J:155070
Mainen ZF; Jia Z; Roder J; Malinow R. 1998. Use-dependent AMPA receptor block in mice lacking GluR2 suggests postsynaptic site for LTP expression. Nat Neurosci 1(7):579-86. PubMed: 10196565 MGI: J:50786
Mead AN; Brown G; Le Merrer J; Stephens DN. 2005. Effects of deletion of gria1 or gria2 genes encoding glutamatergic AMPA-receptor subunits on place preference conditioning in mice. Psychopharmacology (Berl) 179(1):164-71. PubMed: 15619119 MGI: J:110154
Mead AN; Stephens DN. 2003. Involvement of AMPA receptor GluR2 subunits in stimulus-reward learning: evidence from glutamate receptor gria2 knock-out mice. J Neurosci 23(29):9500-7. PubMed: 14573529 MGI: J:86306
Medvedev NI; Rodriguez-Arellano JJ; Popov VI; Davies HA; Tigaret CM; Schoepfer R; Stewart MG. 2008. The glutamate receptor 2 subunit controls post-synaptic density complexity and spine shape in the dentate gyrus. Eur J Neurosci 27(2):315-25. PubMed: 18215230 MGI: J:132175
Meng Y; Zhang Y; Jia Z. 2003. Synaptic transmission and plasticity in the absence of AMPA glutamate receptor GluR2 and GluR3. Neuron 39(1):163-76. PubMed: 12848940 MGI: J:84336
Panicker S; Brown K; Nicoll RA. 2008. Synaptic AMPA receptor subunit trafficking is independent of the C terminus in the GluR2-lacking mouse. Proc Natl Acad Sci U S A 105(3):1032-7. PubMed: 18195349 MGI: J:131170
Taylor EW; Wang K; Nelson AR; Bredemann TM; Fraser KB; Clinton SM; Puckett R; Marchase RB; Chatham JC; McMahon LL. 2014. O-GlcNAcylation of AMPA receptor GluA2 is associated with a novel form of long-term depression at hippocampal synapses. J Neurosci 34(1):10-21. PubMed: 24381264 MGI: J:205592
Van Damme P; Braeken D; Callewaert G; Robberecht W; Van Den Bosch L. 2005. GluR2 deficiency accelerates motor neuron degeneration in a mouse model of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 64(7):605-12. PubMed: 16042312 MGI: J:104951
Wang S; Jia Z; Roder J; Murphy TH. 2002. AMPA receptor-mediated miniature synaptic calcium transients in GluR2 null mice. J Neurophysiol 88(1):29-40. PubMed: 12091530 MGI: J:103180
Yan J; Zhang Y; Jia Z; Taverna FA; McDonald RJ; Muller RU; Roder JC. 2002. Place-cell impairment in glutamate receptor 2 mutant mice. J Neurosci 22(3):RC204. PubMed: 11826150 MGI: J:75591
Zhou Z; Hu J; Passafaro M; Xie W; Jia Z. 2011. GluA2 (GluR2) regulates metabotropic glutamate receptor-dependent long-term depression through N-cadherin-dependent and cofilin-mediated actin reorganization. J Neurosci 31(3):819-33. PubMed: 21248105 MGI: J:168565

Pricing & Availability

Cryo Recovery

Domestic
International

Live Mouse

Age

Genotype

Price

weeks

Cryorecovery - Pricing

Service	Genotype	Price
	Heterozygous or wildtype for Gria2<tm1Rod>/

Progeny testing is not required

The average number of mice provided from recovery of our cryopreserved strains is 10. The total number of animals provided, their gender and genotype will vary. We will fulfill your order by providing at least two pair of mice, at least one animal of each pair carrying the mutation of interest. Please inquire if larger numbers of animals with specific genotype and genders are needed. Animals typically ship between 10 and 14 weeks from the date of your order. If a second cryorecovery is needed in order to provide the minimum number of animals, animals will ship within 25 weeks.

The genotypes of animals provided may not reflect the mating scheme utilized by The Jackson Laboratory prior to cryopreservation, or that discussed in the strain description. Please inquire about possible genotypes which will be recovered for this specific strain. The Jackson Laboratory cannot guarantee the reproductive success of mice shipped to your facility. If the mice are lost after the first three days (post-arrival) or do not produce progeny at your facility, a new order and fee will be necessary.

Cryorecovery to establish a Dedicated Supply for greater quantities of mice. Mice recovered can be used to establish a dedicated colony to contractually supply you mice according to your requirements. Price by quotation.

Payment Terms and Conditions

Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.

The Jackson Laboratory's Genotype Promise

The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project.

Terms Of Use

Terms of Use

General Terms and Conditions

Questions about Terms of Use

Additional Use Restrictions Apply

Use of MICE by companies or for-profit entities requires a license prior to shipping.

Licensing Information

Phone: 207-288-6470

Email: TechTran@jax.org

JAX® Mice, Products & Services Conditions of Use

"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCT(S)" means biological materials supplied by JACKSON, and their derivatives. "SERVICES" means projects conducted by JACKSON for other parties that may include but are not limited to the use of MICE or PRODUCTS. "RECIPIENT" means each recipient of MICE, PRODUCTS, or SERVICES provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE, PRODUCTS or SERVICES from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON’s prior written authorization.

No Warranty

MICE, PRODUCTS AND SERVICES ARE PROVIDED "AS IS". JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.

Credit for PRODUCTS or SERVICES

In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of, PRODUCTS or SERVICES, JACKSON will, at its option, provide credit or replacement for the PRODUCT received or the SERVICES provided; JACKSON makes no other representations and this shall be the exclusive remedy of the purchaser. Please note specific policy for live mice.

Animal Care and Use for SERVICES

Consistent with the requirement for a written understanding regarding animal care and use, the JACKSON Animal Care and Use Committee will review the animal care and use protocol(s) associated with any SERVICES to be performed at JACKSON, and JACKSON shall have ultimate responsibility and authority for the care of animals while on site or in JACKSON custody.

No Liability

In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS, or SERVICES, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS, or SERVICES from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.

MICE, PRODUCTS or SERVICES are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.

The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or SERVICES. In addition, special terms and conditions of sale of certain MICE, PRODUCTS, or SERVICES may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and SERVICES by JACKSON, and by its licensees and distributors.

Acceptance of delivery of MICE, PRODUCTS or SERVICES shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or SERVICES by JACKSON.

Also Known As: GluR2 KO

Donating Investigator

Genetic overview

Research Applications

Base Price

Detailed Description

Control Suggestions

Additional Information

Selected References

Gria2tm1Rod

Allele Symbol: Gria2tm1Rod

Disease Terms

Research Areas By Genotype

This mouse can be used to support research in many areas including:

Genotype: Gria2tm1Rod related

Mammalian Phenotype Terms by Genotype

Genotype: Gria2tm1Rod/Gria2tm1Rodinvolves: 129S1/Sv * 129X1/SvJ * CD-1

mortality/aging

behavior/neurological phenotype

nervous system phenotype

growth/size/body region phenotype

Genotype: Gria2tm1Rod/Gria2+B6.129-Gria2tm1Rod/J

nervous system phenotype

homeostasis/metabolism phenotype

cellular phenotype

Genotype: Gria2tm1Rod/Gria2tm1RodB6.129-Gria2tm1Rod/J

nervous system phenotype

behavior/neurological phenotype

homeostasis/metabolism phenotype

cellular phenotype

References

Additional References

Additional - Gria2tm1Rod related

Genotyping Protocols

Breeding Considerations

Citation

Animal Health Reports

Production of mice from cryopreserved embryos or sperm occurs in a maximum barrier room, G200

Live Mouse

Cryorecovery - Pricing

Progeny testing is not required

Payment Terms and Conditions

The Jackson Laboratory's Genotype Promise

Terms of Use

Additional Use Restrictions Apply

Licensing Information

JAX® Mice, Products & Services Conditions of Use

No Warranty

Credit for PRODUCTS or SERVICES

Animal Care and Use for SERVICES

No Liability

Gria2^tm1Rod

Allele Symbol: Gria2^tm1Rod

Genotype: Gria2^tm1Rod related

Genotype: Gria2^tm1Rod/Gria2^tm1Rod
involves: 129S1/Sv * 129X1/SvJ * CD-1

Genotype: Gria2^tm1Rod/Gria2⁺
B6.129-Gria2^tm1Rod/J

Genotype: Gria2^tm1Rod/Gria2^tm1Rod
B6.129-Gria2^tm1Rod/J

Additional - Gria2^tm1Rod related